Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 Life Science Investing
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635 Life Science Investing
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 Life Science Investing
Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin Artificial Intelligence Investing
Taysha Gene Therapies to Release Third Quarter 2025 Financial Results and Host Conference Call and Webcast on November 4 Biotech Investing
Nextech3D.ai Reports Milestone YTD Revenue Growth for AI Matchmaking in 2025 with a 95% Gross Margin Artificial Intelligence Investing
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025 Biotech Investing
Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference Biotech Investing
